Where Sanofi appears
7 total
… 2015 (21:30 CET / 20:30 BST/ 15:30 EDT / 12:30 PDT). The call will be available through audio webcast at www.sanofi.com and www.regeneron.com and also via the following telephone numbers: France: +33 (0) 1 70 8071 53 UK: +44 (0) 203 107 02...
…t-of-pocket costs to patients will vary depending on insurance status and eligibility for patient assistance. Sanofi and Regeneron are committed to ensuring that patients in the U.S. who are prescribed Praluent are able to access the medici...
…fda. gov/medwatch or call 1 -800-FDA-1088______ Please click here for the full Prescribing Information. About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patien...
…t-of-pocket costs to patients will vary depending on insurance status and eligibility for patient assistance. Sanofi and Regeneron are committed to ensuring that patients in the U.S. who are prescribed Praluent are able to access the medici...
…remains a leading concern in the U.S. and globally," said Olivier Brandicourt, M.D., Chief Executive Officer, Sanofi. "Praluent demonstrates the power of the Sanofi and Regeneron alliance to deliver a first-in-class therapy in the U.S. for...
…fda. gov/medwatch or call 1 -800-FDA-1088______ Please click here for the full Prescribing Information. About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patien...
…lication for Praluent in the European Union in September 2015. Investor Relations Conference Call on Praluent Sanofi and Regeneron will be hosting a conference call for the financial community on Praluent® (alirocumab) Injection for the tre...
